Table 1

Positive immunoreactivity of IIP test on different tissue sections of treatment groups.
Experiment/Organ
 A (Day 21 p.i.)
 B (Day 21 p.i.)
 C (Day 13–14 p.i.)
 D (Day 21 p.i.)


Group


v
 pv
 v
 pv
 v
 pv
 v
 pv
Brain
 0/3
 0/3
 0/3
 0/3
 0/3
 0/3
 0/3
 0/3
Salivary gland
 0/3
 1/3
 0/3
 1/3
 0/3
 0/3
 1/3
 2/3
Heart
 0/3
 0/3
 0/3
 0/3
 0/3
 0/3
 0/3
 0/3
Lung
 0/3
 2/3
 1/3
 3/3
 2/3
 3/3
 3/3
 3/3
Spleen
 0/3
 1/3
 0/3
 2/3
 2/3
 3/3
 2/3
 3/3
Liver
 0/3
 1/3
 0/3
 2/3
 1/3
 3/3
 1/3
 3/3
Kidney
 0/3
 2/3
 0/3
 2/3
 2/3
 3/3
 2/3
 3/3
Testes
 0/3
 0/3
 -
 -
 -
 -
 -
 -
Ovary
 -
 -
 0/3
 0/3
 0/3
 0/3
 0/3
 0/3
Uterus
 -
 -
 1/3
 3/3
 2/3
 3/3
 3/3
 3/3
Neonate
 -
 -
 -
 -
 6/15
 12/15
 -
 -
Placenta
 -
 -
 -
 -
 -
 -
 12/15
 8/10
Fetus
 -
 -
 -
 -
 -
 -
 9/15
 6/10
Embryo*
 -
 -
 -
 -
 -
 -
 -
 5/5

Note: Abbreviations: v = virus-infected and pv = virus-infected with immunosuppression.

* = eroded placenta and developing embryo in uterus at ≤ 7 days of pregnancy.

0/3 = no detectable positive result over triplicate sample trials in all three rats.

Loh et al. Virology Journal 2006 3:42   doi:10.1186/1743-422X-3-42